Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1996
12/12/1996CA2221637A1 Human g-protein receptor hcegh45
12/12/1996CA2221616A1 Human g-protein receptor hibef51
12/12/1996CA2221453A1 Method for expression and isolation of biologically active molecules in urine
12/12/1996CA2221451A1 Cloning and expression of thermostable muts genes and proteins and uses therefor
12/12/1996CA2221274A1 Human g-protein receptor hgber32
12/12/1996CA2221258A1 Use of neuro-derived fetal cell lines for transplantation therapy
12/12/1996CA2221116A1 G-protein parathyroid hormone receptor hltdg74
12/12/1996CA2220979A1 Human g-protein receptor hpraj70
12/12/1996CA2220912A1 Human ccn-like growth factor
12/12/1996CA2220130A1 Kunitz type plasma kallikrein inhibitors
12/12/1996CA2220060A1 A method for increasing the electrotransport flux of polypeptides
12/12/1996CA2219821A1 Compositions for expression of proteins in host cells using a preprocollagen signal sequence
12/12/1996CA2218329A1 Fibroblast growth factor-11
12/12/1996CA2217301A1 Fibroblast growth factor 15
12/12/1996CA2217229A1 Pineal gland specific gene-1
12/12/1996CA2217216A1 Human chemokine beta-13
12/12/1996CA2216912A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2215286A1 Human criptin growth factor
12/12/1996CA2212992A1 Fibroblast growth factor-14
12/11/1996EP0747701A1 Micelle protection assay
12/11/1996EP0747489A2 Nucleic acid probes and amplification oligonucleotides for Neisseria species
12/11/1996EP0747485A1 Production of proteins using homologous recombination
12/11/1996EP0747484A1 Upstream activator sequences and recombinant promoter sequences functional in yarrowia and vectors containing them
12/11/1996EP0747483A2 Fermentative carotenoid production
12/11/1996EP0747482A2 Hepatitis GB virus recombinant proteins and uses thereof
12/11/1996EP0747481A1 Epstein-Barr virus peptides and antibodies against these peptides
12/11/1996EP0747480A1 Oligonucleotides specific for cytokine signal transducer gp130 mRNA
12/11/1996EP0747479A1 Template and primer based synthesis of enzymatically cleavable oligonucleotides
12/11/1996EP0747394A2 Hepatitis GB virus synthetic peptides and uses thereof
12/11/1996EP0747388A1 Method and kit for purifying nucleic acids
12/11/1996EP0747387A2 Method and kit for purifying nucleic acids
12/11/1996EP0747386A2 Method and antisense oligonucleotides to Interleukin-6 receptor mRNA for inhibiting cellular proliferation
12/11/1996EP0747351A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/11/1996EP0746974A2 Production of improved rapeseed exhibiting a reduced saturated fatty acid content
12/11/1996EP0746626A1 Method for carbohydrate engineering of glycoproteins
12/11/1996EP0746625A1 Targetable vector particles
12/11/1996EP0746624A1 Vector for liver-specific gene therapy
12/11/1996EP0746623A1 Promoter from a lipid transfer protein gene
12/11/1996EP0746622A1 Antifungal proteins, dna coding therefor, and hosts incorporating same
12/11/1996EP0746621A1 Expression of proteins on bacterial surface
12/11/1996EP0746620A1 NOVEL $i(EXO)-(1$m(7)4)-$g(b)-D GALACTANASE
12/11/1996EP0746619A1 Human phosphodiesterase type ivc, and its production and use
12/11/1996EP0746618A1 A method of preparing a variant of a lipolytic enzyme
12/11/1996EP0746617A1 Dna encoding a pectin esterase, cells and plants derived therefrom
12/11/1996EP0746616A1 Expression of the glucose oxidase gene in transgenic organisms
12/11/1996EP0746615A1 Dna constructs, cells and plants derived therefrom
12/11/1996EP0746614A1 Method and reagent for inhibiting the expression of disease related genes
12/11/1996EP0746613A1 Recombinant humanized anti-fb5 antibodies
12/11/1996EP0746612A1 Synthetic polynucleotides
12/11/1996EP0746611A1 METHOD FOR INCREASING PRODUCTION OF DISULFIDE BONDED RECOMBINANT PROTEINS BY $i(SACCHAROMYCES CEREVISIAE)
12/11/1996EP0746610A1 Mammalian cloning by embryonic stem cell (esc) nuclear transplantation and esc
12/11/1996EP0746609A1 Transgenic non-human animals capable of producing heterologous antibodies
12/11/1996EP0746607A1 Recombinant xylanase
12/11/1996EP0746605A1 Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity
12/11/1996EP0746569A1 Receptor-binding determinant from leukaemia inhibitory factor
12/11/1996EP0746565A1 Novel bombesin-related peptides
12/11/1996EP0746398A1 Antibody purification
12/11/1996EP0746343A1 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE $i(IN VIVO) OR $i(EX VIVO)
12/11/1996EP0746336A1 Prodrugs activated by targeted catalytic proteins
12/11/1996EP0746333A1 Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv)
12/11/1996EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
12/11/1996EP0746326A1 Oligomeric compounds having nitrogen-containing linkages
12/11/1996EP0695305A4 Method of forming oligonucleotides
12/11/1996EP0593435B1 A polypeptide
12/11/1996EP0496832B1 Inhibition of padgem-mediated cell binding
12/11/1996EP0491865B1 Conjugate vaccine for group b streptococcus
12/11/1996CN1137826A Method and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disorders
12/11/1996CN1137806A Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
12/11/1996CN1137757A Compositions and methods for stimulating megakaryocyte growth and differentiation
12/11/1996CN1137567A Autonomic replicative and liver cancer specific expressive guide gene transfer system and its application
12/11/1996CN1137566A Making-up high effective expression vector using E. coil intensified subsample sequence and application thereof
12/11/1996CN1137565A Vector for producing transgenic plant and its method
12/10/1996US5583278 Genetic engineered drug testing animal
12/10/1996US5583210 Methods and compositions for controlling plant development
12/10/1996US5583209 Produced by isolation and recombination of human and porcine factor viii
12/10/1996US5583202 Antigenized antibodies and genes
12/10/1996US5583201 Using apolipoprotein e variant as marker of peripheral nerve damage
12/10/1996US5583116 Applying a polynucleotide primer to the colony tumor cell
12/10/1996US5583107 Agents affecting thrombosis and hemostasis
12/10/1996US5583046 Polypeptides
12/10/1996US5583040 Mutation of repA protein
12/10/1996US5583038 Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins
12/10/1996US5583036 From somatic cells; genetic engineering
12/10/1996US5583035 For blocking messenger rna and suppressing virus reproduction
12/10/1996US5583034 Enhancement of adoptosis using antisense oligonucleotides
12/10/1996US5583033 T lymphocyte precursor
12/10/1996US5583032 Using a chimeric molecule made up of an antisense oligonucleotide attached to a 2',5'-oligoadenylate molecule; antisense oligonucleotide is hybridized to sense strand of rna in presence of 2',5'-dependent rnase
12/10/1996US5583028 Recombinant vaccinia virus as DNA constructs encoding HSV glycoproteins
12/10/1996US5583025 Enzymes for the production of 2-keto-L-gulonic acid
12/10/1996US5583024 Expressing in procaryotic or eucaryotic cell, a lysate of the cell or a cell-free protein translation system a recombinant dna code for coleoptera
12/10/1996US5583023 Cloning of heterologous dna into endonuclease restriction sites and expression of dna inserted therein
12/10/1996US5583022 Defective recombinant retrovirus
12/10/1996US5583021 Genetic engineering
12/10/1996US5583016 Isolated, purified recombinant nucleic acid fragment comprising oligonucleotide having sequence complementary or identical to human genomic dna sequence encoding rna component of human telomerase
12/10/1996US5583013 Expression in a microorganism transformed with a replicable cloning vehicle; encoding dna is under the operative control of an expression control region
12/10/1996US5583009 Insertion of vertebrate gene locus control regions linked to a structural gene of interest; cistron promoter; agonist; gene expression
12/10/1996US5583005 Binding a mixture of labelled monoclonal antibodies to the human ige which has been bound to the immobilized antibody
12/10/1996US5582995 Methods of screening for compounds which inhibit the direct binding of Ras to Raf
12/10/1996US5582994 Aminopsoralen compounds for use in decontaminating clinical samples
12/10/1996US5582993 Compositions and methods for the detection of bacteria in the genus vibrio